参考文献/References:
[1] 张凯. 中国前列腺癌外科治疗专家共识[J]. 中华外科杂志, 2017,10(55): 721-724．
[2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[3] Bubendorf L, Sch?pfer A,Wagner U, et al. Metastatic patterns of prostate cancer: An autopsy study of 1589 patients[J]. Hum Pathol, 2000, 31(5): 578-583.
[4] Psaila B, Lyden D. The metastatic niche: adapting the foreign soil[J]. Nat Rev Cancer, 2009, 9(4): 285-293.
[5] Ojo D, Lin X, Wong N, et a1. Prostate cancer stem-like cells contribute to the development of castration-resistant prostate cancer[J]. Cancers(Basel), 2015, 7(4): 2290-2308.
[6] 王野, 高旭, 杨庆, 等. 前列腺癌骨转移发生机制的研究进展[J].中华泌尿外科杂志 , 2015, 36(9): 715-717.
[7] Aydemir H, Kumsar ?. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study[J]. J Urol, 2015, 194(3): 853-854.
[8] Crispen PL, Blute ML. Role of cytoreductive nephrectomy in the era of targeted therapy for renal cell carcinoma[J]. Curt Urol Rep, 2012.13(1): 38-46．
[9] Polcher M, Zivanovic O, Chi DS. Cytoreductive surgery for advanced ovarian cancer[J]. Womens Health(Lond), 2014, 10(2): 179-90.
[10] Agarwal S, Liu JH, Crisera CA, et al. Survival in breast cancer patients undergoing immediate breast reconstruction[J]. Breast J, 2010, 16(5): 503-509.
[11] Qin XJ, Ma CG, Ye DW, et a1. Tumor cytoreduction results in better response to androgen-ablation-a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer[J]. Urol Oncol, 2012, 30(2): 145-149.
[12] Gratzke C, Engel J, Stief CG. Role of radical prostatectomy in clinically non-organ-confined prostate cancer[J]. CurrUrol Rep, 2014, 15(11): 455.
[13] Culp SH, Schellhammer PF, Williams MB. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study[J]. Eur Urol, 2014, 65(6): 1058-1066.
[14] L?ppenberg B, Dalela D, Karabon P, et al. The impact of local treatment on overall survival in patients with metastatic prostate cancer on diagnosis: a National Cancer Data Base analysis[J]. Eur Urol, 2017, 72(1): 14-19.
[15] Satkunasivam R, Kim AE, Desai M, et al. Radical prostatectomy or external beam radiation therapy vs no local therapy for survival benefit in metastatic prostate cancer: a SEER-Medicare analysis[J]. J Urol, 2015, 194(2): 378-385.
[16] Poelaert F, Verbaeys C, Rappe B, et al. Cytoreductive prostatectomy for metastatic prostate cancer: first lessons learned from the multicentric prospective local treatment of metastatic prostate cancer (LoMP) trial[J]. Urology, 2017, 106: 146-152.
[17] Fossati N, Trinh QD, Sammon J, et a1. Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study[J]. Eur Urol, 2015, 67(1): 3-6.